ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Immune Cell Subset Profiles in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts) Desensitized with Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody) Followed by Transplantation (Tx)

    S. Ge1, M. Chu1, A. D. Guzman1, E. D. Ortiz1, A. Vo2, N. Ammerman2, S. C. Jordan2, M. Toyoda1

    1Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA, 2Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: IL-6, B cell growth factor, increases follicular T helper cell (Tfh) activity, promoting plasmablast (PB) and plasma cell (PC) differentiation, and antibody production. A…
  • 2020 American Transplant Congress

    De Novo Dosing and Trough Attainment Trends of Extended-Release Tacrolimus in the Absence of Dose Adjustments

    M. J. Moritz1, D. R. Stevens2, U. Meier-Kriesche2, T. A. Horwedel2

    1Department of Surgery, Lehigh Valley Health Network, Allentown, PA, 2Veloxis Pharmaceuticals, Cary, NC

    *Purpose: Initial dosing of tacrolimus extended-release tablets (LCPT) was 0.17 mg/kg/day in the pivotal trial in de novo kidney transplant recipients. Dosing subsequent to the…
  • 2020 American Transplant Congress

    Liver Live Donor Champion: Advocacy Training to Facilitate Identification of Live Liver Donors

    A. D. Love1, L. R. Herbst1, D. R. Helfer1, L. Kurman2, M. G. Bowring1, S. R. Weeks1, E. King1, D. L. Segev1, J. Garonzik Wang1

    1Surgery, The Johns Hopkins School of Medicine, Baltimore, MD, 2Surgery, The Johns Hopkins Hospital, Baltimore, MD

    *Purpose: Although live donor liver transplantation (LDLT) may help address organ shortage, patients lack knowledge about living donation and are reluctant to speak to potential…
  • 2020 American Transplant Congress

    Liver Transplantation in Patients Requiring Pre-Transplant Mechanical Ventilation

    T. Ito, A. Aziz, A. E. Murray, S. Younan, J. DiNorcia III, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

    The Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA

    *Purpose: Increasing transplant candidate acuity has resulted in more patients requiring perioperative intensive care and mechanical ventilation prior to liver transplantation (LT). However, studies on…
  • 2020 American Transplant Congress

    Bile Microbiology and Antibiotic Susceptibility in Liver Transplant Recipients versus Non-Transplant Population

    S. Suh, Y. Choi

    Surgery, Chung-Ang University Hospital, Seoul, Korea, Republic of

    *Purpose: The signs and symptoms of biliary infection in liver transplantation (LT) recipients are frequently subtle because of immunosuppression, thereby delaying its diagnosis and increasing…
  • 2020 American Transplant Congress

    Pharmacist Management after Preemptive Monitoring Conversion as a Component of a Cytomegalovirus Antiviral Stewardship Program at a Large Transplant Center

    C. Wong, M. Jorgenson, J. Descourouez, K. Goldrosen, C. Saddler, J. Smith, D. Mandelbrot

    UW Health, Madison, WI

    *Purpose: Cytomegalovirus (CMV) in solid organ transplant (SOT) is associated with negative graft and patient outcomes. Prophylactic agents of choice have substantial cytotoxicity, and patients…
  • 2020 American Transplant Congress

    Polyoma Virus Infection in Renal Transplant Recipients Using Tacrolimo and Everolimo

    P. M. Souza1, C. Ribeiro1, S. C. Miranda1, A. S. Alvarenga1, C. R. Felipe1, G. Marques1, G. P. Tarcia1, L. L. Braga2, L. S. Ferreira Boy2, M. L. Martins2

    1Nephrology, Santa Casa de Belo Horizonte, Belo Horizonte, Brazil, 2Scientific Technical Development Management, Hemominas Foundation, Belo Horizonte, Brazil

    *Purpose: Seropositivity for polyoma virus can reach 80% in kidney transplant recipients, with 1 to 10% polyoma associated nephropathy which negatively influences graft survival. Therefore,…
  • 2020 American Transplant Congress

    Developing a Patient Specific Search of Heart Transplant Programs: Feedback from Heart Transplant Candidates and Recipients

    W. T. McKinney1, M. J. Bruin2, C. R. Schaffhausen1, S. Chu2, J. Synder3, C. M. Martin4, T. Alexy4, B. L. Kasiske5, A. K. Israni1

    1Nephrology, Hennepin Healthcare Research Institute, Minneapolis, MN, 2College of Design, University of Minnesota, Minneapolis, MN, 3Hennepin Healthcare Research Institute, Minneapolis, MN, 4Cardiology Division, University of Minnesota Department of Medicine, Minneapolis, MN, 5Department of Medicine, Hennepin Healthcare, Minneapolis, MN

    *Purpose: Patients seeking a heart transplant must contemplate numerous factors when making decisions regarding their care. Waitlist acceptance criteria, donor acceptance practices and outcomes often…
  • 2020 American Transplant Congress

    The Histological Picture of Indication Biopsies in the First Days after Renal Transplantation

    E. Van Loon, M. Coemans, A. Senev, D. Kuypers, M. Emonds, M. Naesens

    Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

    *Purpose: In preclinical studies, ischemia reperfusion injury and older donor age are associated with renal inflammation in the early phase after transplantation. In human kidney…
  • 2020 American Transplant Congress

    Stem Cell and Novel Neurotrophic Factors to Promote Functional Outcomes in Limb Transplantation

    S. K. Salgar, J. Weiss, C. Phillips, E. Malin, V. Gorantla, J. Harding

    Clinical Investigation, Madigan Army Medical Center, Tacoma, WA

    *Purpose: Recently, transplantation of hand and face has become a new clinical specialty. The objective of this study was to determine whether adult Mesenchymal Stem…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences